TrialNeurology2018
Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS.
Mark Tullman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled ittrialcites it
TrialNeurology2018
Mark Tullman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.